Affiliation:
1. MountainView Hospital, Sunrise Health Graduate Medical Education Consortium, Las Vegas, NV
2. VA Southern Nevada Healthcare System, Las Vegas, NV
Abstract
Abstract
The addition of aromatase inhibitors (AI) has improved cancer-related outcomes in post-menopausal patients with estrogen receptor-positive breast cancer. However, AI can be associated with a constellation of adverse musculoskeletal effects that comprises bone loss, arthralgia, myalgia, and tendinopathy. This medication complication, known as aromatase inhibitor-associated musculoskeletal syndrome (AIMSS), can limit treatment tolerability in many patients due to the high prevalence of AIMSS among those on AI. The hand and wrist are the most affected joints in AIMSS, with patients presenting with symmetric arthralgia, stiffness, and tendinopathy. Radioulnar joint subluxation with extensor tendon tear has not been previously reported in patients with AIMSS. This is a case report of a 72-year-old breast cancer survivor on an AI presenting with chronic dominant wrist pain, weakness, and 5th digit finger drop. An extensor digitorum minimi tendon tear and radioulnar instability were identified using diagnostic musculoskeletal ultrasonography. This case illustrates the utility of in-office ultrasonography combined with dynamic examination for the often underrecognized pathology associated with AIMSS in breast cancer survivors.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exemestane;Reactions Weekly;2024-07-06